We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
International Journal of Oral Implantology
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Int J Oral Implantol (Berl) 3 (2010), No. 4     20. Dec. 2010
Int J Oral Implantol (Berl) 3 (2010), No. 4  (20.12.2010)

Page 315-322, PubMed:21180684


Clinical evaluation of Tiny 2.5- and 3.0-mm narrow-diameter implants as definitive implants in different clinical situations: a retrospective cohort study
Anitua, Eduardo / Errazquin, Jose M. / de Pedro, José / Barrio, Pedro / Begona, Leire / Orive, Gorka
Aim: The aim of the present study was to assess retrospectively the survival of narrow-diameter implants (2.5 and 3 mm in diameter) in patients with insufficient bone ridge thickness for placement of standard-diameter implants.
Material and methods: Fifty-one patients with 89 inserted narrow-diameter implants (2.5 and 3.0 mm) were included. Patients were treated with one or more narrow-diameter implants between June 2004 and December 2005. The observation period for all included implants was at least 3 years after implant loading. Outcome measures were implant survival, complications and marginal bone level changes evaluated on panoramic radiographs.
Results: The mean follow-up period for all implants was 48 months. Only one implant was lost, yielding survival rates of 98.9% and 98.0% for the implant- and subject-based analyses, respectively. Six complications were reported. Twenty-four months after implant insertion, mean bone loss was 1.26 mm (SD 0.51).
Conclusions: Narrow-diameter implants can be successfully used to treat narrow bone ridges up to 3 years after loading.

Keywords: failure, long-term follow-up, narrow-diameter implants, narrow implants, plasma rich in growth factors (PRGF), survival analysis